β-
elemene, a Curcuma wenyujin
plant extract, has been used widely as a
tumor adjuvant therapeutic agent. However, how to obtain optimum
therapeutic effects by combining this compound with other agents remain unclear. In this study, we found that β-
elemene, which alone had little effect on
hepatocellular carcinoma (HCC) cell proliferation, exerted a synergistic anti-proliferative effect in HCC cells when dosed in combination with
oxaliplatin, which increased the amounts of
platinum accumulation and
platinum-
DNA adduct significantly and augmented the
oxaliplatin-induced apoptosis. Western blot and
laser scanning confocal microscopy studies indicated that β-
elemene enhanced the sensitivity of HCC cells to
oxaliplatin by upregulating
copper transporter 1 (CTR1), a major controller of intracellular
platinum accumulation. In an orthotopic
transplantation HCC model in nude mice, HCC
tumor growth was inhibited significantly by
oxaliplatin combined with β-
elemene, as compared with
oxaliplatin alone. Notably, CTR1
protein expression in xenograft HCC was upregulated in mice who received β-
elemene treatment. Taken together, our findings show that β-
elemene can block the reduction of CTR1 resulting from
oxaliplatin treatment, and therefore has a synergistic anti-HCC effect with
oxaliplatin by enhancing cellular uptake of
oxaliplatin. The synergistic effects of β-
elemene and
oxaliplatin deserve further evaluation in clinical settings.